| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |